Average Co-Inventor Count = 4.30
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. H. Lundbeck A/s (6 from 506 patents)
2. Leo-pharma A/s (5 from 67 patents)
3. Union Therapeutics A/s (3 from 22 patents)
14 patents:
1. 11981681 - Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
2. 11384096 - Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
3. 11292799 - Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
4. 10851116 - Bicyclic amines as novel JAK kinase inhibitors
5. 10799507 - 5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2.5]octane-8-carboxylic acid derivatives as novel JAK kinase inhibitors
6. 9586961 - Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
7. 9346809 - Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors
8. 9233964 - Sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use therof
9. 8299071 - Substituted pyridine derivatives
10. 7812020 - Substituted pyridine derivatives
11. 7683058 - Substituted pyrimidine derivatives
12. 7612068 - Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
13. 7601870 - Substituted aniline derivatives
14. 7067501 - Aryloxyphenyl and arylsulfanylphenyl derivatives